Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...

DARPA launched its “Quantum Benchmarking Initiative,” aiming to chart a path toward an industrially viable quantum computer ...

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell ...

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces the development of novel ...

Bristol Myers Squibb Co. has identified new GTPase KRAS (G12C mutant) inhibitors reported to be useful for the treatment of cancer.

Verastem shows strong late-stage pipeline progress, financial discipline, and a diverse portfolio that support long-term ...

Industry players attribute the subdued growth to an unfriendly regulatory framework at a time when many AMCs already offer ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

The firm will evaluate VS-7375 as both monotherapy and in combination with Eli Lilly's EGFR inhibitor Erbitux in the study.

Croatian food producer Podravka said on Wednesday it has become importer and distributor on the U.S. market of products of ...

SEBI seeks public comments on proposals to expand accreditation agencies to all KRAs and allow provisional onboarding of accredited investors by AIF ...